The recently discovered lantibiotic epilancin 15X produced by Staphylococcus epidermidis 15X154 is active against several pathogenic bacteria, including methicillin‐resistant S. aureus and vancomycin‐resistant Enterococci. Epilancin 15X contains an unusual N‐terminal lactate group (Lac) that could be important for its bioactivity.
